{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:15:49Z","timestamp":1781075749426,"version":"3.54.1"},"reference-count":30,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,5,3]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>In Hong Kong, tuberculin skin test (TST) with a 15\u2009mm cut-off was used at 0 and 3 months for contact screening, but half of future tuberculosis cases might be missed. Follow-on interferon-gamma release assay (IGRA) was added for those with tuberculin reaction of 5\u201314\u2009mm in a pilot programme.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a prospective cohort study. All household contacts of smear-positive tuberculosis aged 12\u201364 registered in Hong Kong Tuberculosis and Chest Service from 1 July 2018 to 30 June 2022 were prospectively tracked through medical records and the territory-wide tuberculosis notification registry for active tuberculosis till 31 December 2022.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among untreated contacts with tuberculin reaction of 5\u201314\u2009mm in either the initial test or second test at 3\u2009months, the tuberculosis rate among those with a follow-on reactive IGRA was significantly higher than those with a non-reactive IGRA (12.44 vs 0.75 per 1000 person-years, relative risk: 16.52, p=0.003). After adjustment for the efficacy of preventive treatment among all treated cases, the estimated proportions of tuberculosis cases captured by the pilot programme criterion of TST\u226515\u2009mm\/TST 5\u201314\u2009mm and IGRA reactive\/TST conversion were similar to those captured by TST cut-offs of 5\u2009mm or 10\u2009mm, despite consistently lower positive rates. With an overall test-positive rate of 54.5%, the pilot programme captured 95.8% of estimated future tuberculosis cases at a relative risk between test-positive and test-negative cases of 19.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Combining TST with follow-on IGRA for those with tuberculin reaction of 5\u201314\u2009mm markedly improves screening of household contacts in an intermediate burden setting.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/thorax-2024-222400","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:10:20Z","timestamp":1748581820000},"page":"650-657","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Combining tuberculin skin test with follow-on interferon gamma release assay markedly improves screening of household contacts"],"prefix":"10.1136","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6819-1961","authenticated-orcid":false,"given":"Chi Kuen","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Health, Centre for Health Protection, Tuberculosis and Chest Service, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chiu","family":"Leung","sequence":"additional","affiliation":[{"name":"Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan Shan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Health, Centre for Health Protection, Tuberculosis and Chest Service, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuk Nor Maria","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Health, Centre for Health Protection, Tuberculosis and Chest Service, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Bun","family":"Tai","sequence":"additional","affiliation":[{"name":"Department of Health, Centre for Health Protection, Tuberculosis and Chest Service, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"2025081509100673000_80.9.650.1","unstructured":"World Health Organization . Implementing the END TB Strategy: the essentials, 2022 update. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240065093 [Accessed 4 Aug 2024]."},{"key":"2025081509100673000_80.9.650.2","unstructured":"WHO Consolidated Guidelines on Tuberculosis: Module 1: Prevention - Infection Prevention and Control. Geneva: World Health Organization, 2022."},{"key":"2025081509100673000_80.9.650.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70210-9"},{"key":"2025081509100673000_80.9.650.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.3954"},{"key":"2025081509100673000_80.9.650.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"2025081509100673000_80.9.650.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03555.x"},{"key":"2025081509100673000_80.9.650.7","first-page":"1","article-title":"IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2025081509100673000_80.9.650.8","unstructured":"National Institute for Health and Clinical Excellence (NICE) . Tuberculosis. 2016. Available: https:\/\/www.nice.org.uk\/guidance\/ng33\/chapter\/Recommendations#latent-tb"},{"key":"2025081509100673000_80.9.650.9","unstructured":"An Advisory Committee Statement (ACS) . Canadian tuberculosis committee (ctc). recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection\u20142010 update. 2010 Available: https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2010-36\/canada-communicable-disease-report-10.html"},{"key":"2025081509100673000_80.9.650.10","unstructured":"Bastian I . Chris coulter and the national tuberculosis advisory committee. department of health and aged care. australian government. position statement on interferon-\u03b3 release assays for the detection of latent tuberculosis infection. Available: https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cdi4104-c [Accessed 4 Aug 2025]."},{"key":"2025081509100673000_80.9.650.11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"2025081509100673000_80.9.650.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30276-0"},{"key":"2025081509100673000_80.9.650.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101815","article-title":"Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis","volume":"56","author":"Hamada","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025081509100673000_80.9.650.14","unstructured":"Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong SAR Government. Annual Report. 2022. Available: https:\/\/www.info.gov.hk\/tb_chest\/en\/contents\/c56.htm"},{"key":"2025081509100673000_80.9.650.15","unstructured":"Tuberculosis and Chest service, Centre for Health protection, Department of Health, Hong Kong SAR Government. Management of latent tuberculosis infection in immunocompetent household contacts. 2024 Available: https:\/\/www.info.gov.hk\/tb_chest\/doc\/1_Guidelines_management%20of%20LTBI_immunocompetent%20household%20contacts_28%20Dec%202020%20FINAL_Clean.pdf"},{"key":"2025081509100673000_80.9.650.16","first-page":"281","article-title":"Early and late tuberculosis risks among close contacts in Hong Kong","volume":"12","author":"Lee","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025081509100673000_80.9.650.17","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12483"},{"key":"2025081509100673000_80.9.650.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714283"},{"key":"2025081509100673000_80.9.650.19","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIY265"},{"key":"2025081509100673000_80.9.650.20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00851-2017","article-title":"Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan","volume":"50","author":"Lee","year":"2017","journal-title":"Eur Respir J"},{"key":"2025081509100673000_80.9.650.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025081509100673000_80.9.650.22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009681","article-title":"Household tuberculosis contact investigation in a tuberculosis-prevalent country: Are the tuberculin skin test and interferon-gamma release assay enough in elderly contacts?","volume":"97","author":"Eom","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2025081509100673000_80.9.650.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00371-7"},{"key":"2025081509100673000_80.9.650.24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00183812"},{"key":"2025081509100673000_80.9.650.25","first-page":"819","article-title":"Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease","volume":"14","author":"Yoshiyama","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025081509100673000_80.9.650.26","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.6.2706-2708.2003"},{"key":"2025081509100673000_80.9.650.27","unstructured":"WHO Operational Handbook on Tuberculosis. Module 1: Prevention - Tuberculosis Preventive Treatment. Geneva: World Health Organization, 2020."},{"key":"2025081509100673000_80.9.650.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00079310"},{"key":"2025081509100673000_80.9.650.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0232OC"},{"key":"2025081509100673000_80.9.650.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2008.01470.x"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:03:27Z","timestamp":1759928607000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,8,15]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/thorax-2024-222400"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222400","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}